Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.4B |
| 2 |
Amazon
AMZN
|
+$2.49B |
| 3 |
NVIDIA
NVDA
|
+$2.18B |
| 4 |
Microsoft
MSFT
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.21B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$1.75B |
| 2 |
Broadcom
AVGO
|
+$1.56B |
| 3 |
Dell
DELL
|
+$1.09B |
| 4 |
SNDK
Sandisk
SNDK
|
+$899M |
| 5 |
T-Mobile US
TMUS
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.39% |
| 2 | Technology | 3.64% |
| 3 | Industrials | 1.09% |
| 4 | Consumer Discretionary | 0.89% |
| 5 | Financials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRDL
10851
Cardiol Therapeutics
CRDL
$216M
| $56.1K | ﹤0.01% |
53,416
-73,541
| -58% | -$93.1K |
|
|
AIFA
10852
All In FutureTech Alliance Inc
AIFA
$18.7M
| $55.5K | ﹤0.01% |
+24,901
| New | +$66.3K |
|
10853
PUT
Upexi
UPXI
$75.7M
| $55.4K | ﹤0.01% |
70,600
+32,400
| +85% | +$37.6K |
|
10854
Wetouch Technology
WETH
$15.3M
| $55.2K | ﹤0.01% |
45,649
+20,275
| +80% | +$31.1K |
|
10855
Gevo
GEVO
$388M
| $54.9K | ﹤0.01% |
36,584
+11,171
| +44% | +$19.7K |
|
|
CAN
10856
CALL
Canaan Creative
CAN
$229M
| $54.9K | ﹤0.01% |
191,100
-62,300
| -25% | -$27.1K |
|
|
DPRO
10857
Draganfly
DPRO
$199M
| $54.8K | ﹤0.01% |
10,116
-172,769
| -94% | -$1M |
|
10858
CALL
Aclaris Therapeutics
ACRS
$814M
| $54.5K | ﹤0.01% |
10,300
-81,900
| -89% | -$365K |
|
10859
PUT
Horizon Technology Finance
HRZN
$314M
| $54.4K | ﹤0.01% |
+11,500
| New | +$49.7K |
|
10860
Coherus Oncology
CHRS
$205M
| $54.1K | ﹤0.01% |
38,663
-1,831
| -5% | -$2.99K |
|
|
EDVA
10861
Endovia Health Sciences, Inc.
EDVA
$1.63M
| $54K | ﹤0.01% |
+87,105
| New | +$90.2K |
|
10862
CALL
Wrap Technologies
WRAP
$98.8M
| $53.9K | ﹤0.01% |
41,800
+600
| +1% | +$847 |
|
10863
PUT
Century Therapeutics
IPSC
$359M
| $53.9K | ﹤0.01% |
+22,000
| New | +$50.3K |
|
10864
PMV Pharmaceuticals
PMVP
$72.7M
| $53.9K | ﹤0.01% |
40,207
-83,807
| -68% | -$108K |
|
10865
CALL
Verastem
VSTM
$665M
| $53.9K | ﹤0.01% |
14,100
-137,300
| -91% | -$664K |
|
10866
CALL
Future Fuel
FF
$245M
| $53.8K | ﹤0.01% |
+11,900
| New | +$51.3K |
|
10867
CALL
Amplify Energy
AMPY
$204M
| $53.7K | ﹤0.01% |
13,500
-11,700
| -46% | -$60.1K |
|
10868
Pacific Biosciences
PACB
$417M
| $53.7K | ﹤0.01% |
31,971
-1,358,099
| -98% | -$1.97M |
|
|
CYPH
10869
PUT
Cypherpunk Technologies Inc
CYPH
$239M
| $53.6K | ﹤0.01% |
87,600
+69,300
| +379% | +$63.3K |
|
10870
Cosmos Holdings
COSM
$27.9M
| $53.4K | ﹤0.01% |
+289,287
| New | +$84K |
|
10871
Caribou Biosciences
CRBU
$136M
| $53.4K | ﹤0.01% |
30,331
+5,356
| +21% | +$10.6K |
|
|
PLG
10872
CALL
Platinum Group Metals
PLG
$175M
| $53.3K | ﹤0.01% |
39,500
+22,300
| +130% | +$37.3K |
|
10873
Playboy Inc
PLBY
$135M
| $53.3K | ﹤0.01% |
43,656
-48,306
| -53% | -$73.3K |
|
|
MGN
10874
Megan Holdings Ltd
MGN
$18.7K
| $53.1K | ﹤0.01% |
350,948
-119,375
| -25% | -$20.6K |
|
|
CHAI
10875
Core AI Holdings Inc
CHAI
$6.79M
| $53.1K | ﹤0.01% |
+74,397
| New | +$79.8K |
|
Similar funds
Jane Street's Q2 2026 Portfolio in Review
As of Q2 2026, Jane Street held 13,869 positions worth $1.21T, up 55% from $777B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jane Street deployed $44.4B of net new capital in Q2 2026, opening 2,565 new positions and adding to 4,995 existing holdings. Its largest new stake was Super Micro Computer Depositary Shares 7% Series A Preferred Stock: 10,590,097 shares worth $550M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Marvell Technology, an estimated $1.75B trimmed.
- Jane Street's largest Q2 2026 buy was Super Micro Computer Depositary Shares 7% Series A Preferred Stock: 10,590,097 shares worth $550M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $17.4B increase.
- Jane Street's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.75B.
- Jane Street fully exited iShares Core US Aggregate Bond ETF in Q2 2026, selling an estimated $239M.
- Jane Street's ten largest holdings make up 32% of its $1.21T portfolio in Q2 2026.
- Jane Street opened 2,565 new positions and closed 2,484 in Q2 2026.
- Jane Street's portfolio value rose 55% quarter-over-quarter to $1.21T.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.